Endopure Testos For Women

Manufacturer
The Wellness Center for Research and Education, Inc. | Apotheca Company
Effective date
2025-06-06
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 20:37:07

Label at a glance#

ProductEndopure Testos For Women
Active ingredientSUS SCROFA HYPOTHALAMUS, SACCHAROMYCES CEREVISIAE RNA, SAW PALMETTO, HERRING SPERM DNA, SUS SCROFA ADRENAL GLAND, HYDROCORTISONE, SUS SCROFA PITUITARY GLAND, TESTOSTERONE, CHELIDONIUM MAJUS WHOLE, THUJA OCCIDENTALIS LEAFY TWIG
Label structure9 sections

Dosage and administration

5 drops orally 2 to 3 times daily between meals. Female: Administer orally, day 1 through 24 of the monthly menstrual cycle, even if menses has ceased. If cycle dates are unknown, day 1 is the first day of the calendar month. Use 5 drops between 7:30 and 8:30 pm and upon waking. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

Hypothalamus Suis 6X, RNA 6X, Sabal Serrulata 6X, DNA 6C, Glandula Suprarenalis Suis 6C, Hydrocortisone (Cortisol) 6C, Hypophysis Suis 6C, Testosterone 6C, Chelidonium Majus 12C, Thuja Occidentalis 12C.

INDICATIONS:

OTC - PURPOSE SECTION

For the temporary relief of the following complaints: liver, hot flashes, and irregular periods.

WARNINGS:

WARNINGS SECTION

If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal around neck is broken or missing.

Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

5 drops orally 2 to 3 times daily between meals.

Female: Administer orally, day 1 through 24 of the monthly menstrual cycle, even if menses has ceased. If cycle dates are unknown, day 1 is the first day of the calendar month. Use 5 drops between 7:30 and 8:30 pm and upon waking.

Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

For the temporary relief of the following complaints: liver, hot flashes, and irregular periods.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized Water, 25% Organic Ethanol

QUESTIONS:

OTC - QUESTIONS SECTION

Manufactured for

The Wellness Center for

Research and Education, Inc.

1237 S. Victoria Ave., Ste. 169

Oxnard, CA 93035

www.wellnesscenter.net

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50181-0074-1

EndoPure

by Theresa Dale, Ph.D, CCN

Homeopathic

TESTOS

(For Women)

HORMONE REJUVENATION SYSTEM

1 FL. OZ. (30 ml)

EndoPure Testos For WomenEndoPure Testos For Women

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50181-0074-12025-06-06C16284748780-1f386c649-bbe5-0266-e053-dadaa90a7c1aDRUG FACTS:
50181-0074-12023-01-30C16284748780-1f386c649-bbe5-0266-e053-dadaa90a7c1aDRUG FACTS:

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50181-007450181-0074-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2eebd4ae-e6c3-4b42-a38c-3678dfb626c604702cd6-ce49-43d2-bc5e-7a9e19815fe72025-06-06WarningsExact identifier
spl id: 2eebd4ae-e6c3-4b42-a38c-3678dfb626c6
spl set id: 04702cd6-ce49-43d2-bc5e-7a9e19815fe7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.